✦ LIBER ✦

BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD)

✍ Scribed by W. J. Lukiw; P. Handley; L. Wong; D. R. Crapper McLachlan

Publisher: Springer
Year: 1992
Tongue: English
Weight: 862 KB
Volume: 17
Category: Article
ISSN: 0364-3190
DOI: 10.1007/bf00968788

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aphasia in senile dementia of the alzhei

Aphasia in senile dementia of the alzheimer type

✍ Kathy Faber-Langendoen; Dr. John C. Morris; John W. Knesevich; Emily LaBarge; J. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 658 KB

Milacemide: Safety assessment in senile

Milacemide: Safety assessment in senile dementia of the Alzheimer type

✍ Maurice W. Dysken; T. Daniel Fakouhi; Stacy S. Skare; Joseph Mendels; Peter LeWi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB

Milacemide, both an MAO-B inhibitor and a prodrug for glycine, has demonstrated cognitive enhancing effects in animal models, in cognitively intact young and elderly, and has been suggested as a potential treatment for senile dementia of the Alzheimer type (SDAT). This multicenter open-label trial e

Cerebrospinal fluid acetylcholinesterase

Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type

✍ Dr Larry Tune; Stephen Gucker; Marshal Folstein; Leslie Oshida; Joseph T. Coyle 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 2 views

Acetylcholinesterase (AChE) activity was measured in cerebrospinal fluid (CSF) samples from 36 individuals, including 12 persons with Alzheimer's disease, 12 normal controls, and 12 patients with other dementias. AChE activity also was measured in 47 normal subjects whose ages ranged from 20 to 84 t

Abnormal pattern electroretinograms in p

Abnormal pattern electroretinograms in patients with senile dementia of the alzheimer type

✍ Dr Gary L Trick; Michael C Barris; Michelle Bickler-Bluth 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 668 KB

Some morphometric aspects of the brain i

Some morphometric aspects of the brain in senile dementia of the alzheimer type

✍ Dr. Robert D. Terry; Arthur Peck; Richard DeTeresa; Ruben Schechter; Dikran S. H 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 811 KB

Clinical trials with the cholinergic dru

Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT)

✍ Albert Wettstein; René Spiegel 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 216 KB

The muscarinic agonist RS 86 was administered to patients with Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT) in a series of controlled clinical trials. Daily doses were up to 3.0 mg orally for a maximum duration of 18 weeks. RS 86 produced typical peripheral cholinergic e